Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer

NCT05843292 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Triple-negative Breast Cancer

Interventions

DRUG: Taxane and Carboplatin
DRUG: Short-term Sintilimab
PROCEDURE: Surgery

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]